Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Re-hospitalized Patients With Acute Coronary Syndrome (BoomerangACS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03727984
Recruitment Status : Recruiting
First Posted : November 1, 2018
Last Update Posted : April 9, 2019
Sponsor:
Information provided by (Responsible Party):
Mehdi Zoghi, Cardiovascular Academy Society, Turkey

Brief Summary:
The predictors of re-hospitalization of patients with history of acute coronary syndrome

Condition or disease
Acute Coronary Syndrome

Detailed Description:
The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Demographic, Clinical Characteristics and Medications of Re-hospitalized Patients for Acute Coronary Syndrome
Actual Study Start Date : November 15, 2018
Estimated Primary Completion Date : September 15, 2019
Estimated Study Completion Date : November 15, 2019



Primary Outcome Measures :
  1. Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome [ Time Frame: Up to 1 year ]
    The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code

  2. Cardiovascular Hospitalization [ Time Frame: Up to 1 year ]
    Predictive factors for patients re-admitted with acute coronary



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months. To the best of our knowledge, this is the first study to evaluate the characteristics of re-hospitalized patients for ACS. The case report forms which attached in excel must be filled by investigators case by case based on recorded data.
Criteria

Inclusion Criteria:

Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months

Exclusion Criteria:

Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03727984


Contacts
Layout table for location contacts
Contact: Tarık Kıvrak, Asst.Prof.Dr. +904242333555 tarikkivrak@gmail.com

Locations
Layout table for location information
Turkey
Cardiovascular Academy Society Recruiting
İzmir, Turkey
Contact: Tarık Kıvrak, MD         
Sponsors and Collaborators
Cardiovascular Academy Society, Turkey

Layout table for additonal information
Responsible Party: Mehdi Zoghi, Prof. Dr., Cardiovascular Academy Society, Turkey
ClinicalTrials.gov Identifier: NCT03727984     History of Changes
Other Study ID Numbers: 2018-2
First Posted: November 1, 2018    Key Record Dates
Last Update Posted: April 9, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Mehdi Zoghi, Cardiovascular Academy Society, Turkey:
Myocardial infarction
Hospitalization
Coronary artery disease
Retrospective
Cohort study
Additional relevant MeSH terms:
Layout table for MeSH terms
Acute Coronary Syndrome
Syndrome
Disease
Pathologic Processes
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases